By G HossainPosted on May 1, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Announcing first-quarter results, Biogen CEO Chris Viehbacher admitted that tariffs are “a new topic for us,” but said he does not expect major impacts—at least for 2025. Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal Post navigation Entrada Trims 20% of Employees, Focusing on Research StaffLilly Unfazed as CVS Picks Novo’s Side in Obesity Market Battle